LAURA WILLIAMS: Open Payments
NPI 1508453671 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,574 in 120 payments from 17 companies in 2025. Trend: 2023 $307 · 2024 $1,099 · 2025 $2,574
Food & beverage: $2,574
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $669 |
| Janssen Biotech, Inc. | 13 | $302 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $298 |
| Ardelyx, Inc. | 10 | $223 |
| Celltrion USA Inc. | 9 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $140 |
| Lilly USA, LLC | 4 | $132 |
| GENZYME CORPORATION | 4 | $110 |
| Intercept Pharmaceuticals, Inc. | 3 | $99 |
| Regeneron Healthcare Solutions, Inc. | 4 | $96 |
Products named: TREMFYA, RINVOQ, XIFAXAN, IBSRELA, DUPIXENT, VEGZELMA, SKYRIZI, LINZESS.
Industry payments across MO — which companies pay providers there.
